For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Home > Publications > Publications

Publications

Found 138 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is A  [Clear All Filters]
Journal Article
Awamlh BAl Hussein, Ma X, Christos P, Hu JC, Shoag JE.  2019.  Active Surveillance for Black Men with Low-Risk Prostate Cancer in the United States.. N Engl J Med. 381(26):2581-2582.
Ahmed F, Christos PJ, Singh P, Parashar B, Wernicke AGabriella.  2019.  Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI).. Am J Clin Oncol. 42(5):446-453.
Zhang Y, Zhang Y, Sholle E, Abedian S, Sharko M, Turchioe MReading, Wu Y, Ancker JS.  2020.  Assessing the impact of social determinants of health on predictive models for potentially avoidable 30-day readmission or death.. PLoS One. 15(6):e0235064.
Zhang Y, Zhang Y, Sholle E, Abedian S, Sharko M, Turchioe MReading, Wu Y, Ancker JS.  2020.  Assessing the impact of social determinants of health on predictive models for potentially avoidable 30-day readmission or death.. PLoS One. 15(6):e0235064.
Tummalapalli SLekha, Zelnick LR, Andersen AH, Christenson RH, deFilippi CR, Deo R, Go AS, He J, Ky B, Lash JP et al..  2020.  Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.. J Am Heart Assoc. 9(13):e014385.
Ramkumar N, Suckow BD, Arya S, Sedrakyan A, Mackenzie TA, Goodney PP, Brown JR.  2020.  Association of Sex With Repair Type and Long-term Mortality in Adults With Abdominal Aortic Aneurysm.. JAMA Netw Open. 3(2):e1921240.
Yan PZ, Wang F, Kwok N, Allen BB, Keros S, Grinspan Z.  2019.  Automated spectrographic seizure detection using convolutional neural networks.. Seizure. 71:124-131.
Khalil CAbi, Sulaiman K, Asaad N, AlHabib KF, Alsheikh-Ali A, Jameesh M, Al-Jarallah M, Bulbanat B, AlMahmeed W, Ridha M et al..  2019.  Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40.. Curr Vasc Pharmacol.
Khalil CAbi, Sulaiman K, Asaad N, AlHabib KF, Alsheikh-Ali A, Jameesh M, Al-Jarallah M, Bulbanat B, AlMahmeed W, Ridha M et al..  2019.  Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40.. Curr Vasc Pharmacol.
Khalil CAbi, Sulaiman K, Asaad N, AlHabib KF, Alsheikh-Ali A, Jameesh M, Al-Jarallah M, Bulbanat B, AlMahmeed W, Ridha M et al..  2019.  Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40.. Curr Vasc Pharmacol.
Khalil CAbi, Sulaiman K, Asaad N, AlHabib KF, Alsheikh-Ali A, Jameesh M, Al-Jarallah M, Bulbanat B, AlMahmeed W, Ridha M et al..  2019.  Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40.. Curr Vasc Pharmacol.
Khalil CAbi, Sulaiman K, Asaad N, AlHabib KF, Alsheikh-Ali A, Jameesh M, Al-Jarallah M, Bulbanat B, AlMahmeed W, Ridha M et al..  2019.  Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40.. Curr Vasc Pharmacol.
Khalil CAbi, Sulaiman K, Asaad N, AlHabib KF, Alsheikh-Ali A, Jameesh M, Al-Jarallah M, Bulbanat B, AlMahmeed W, Ridha M et al..  2019.  Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40.. Curr Vasc Pharmacol.
Khalil CAbi, Sulaiman K, Asaad N, AlHabib KF, Alsheikh-Ali A, Jameesh M, Al-Jarallah M, Bulbanat B, AlMahmeed W, Ridha M et al..  2019.  Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40.. Curr Vasc Pharmacol.
Khalil CAbi, Sulaiman K, Asaad N, AlHabib KF, Alsheikh-Ali A, Jameesh M, Al-Jarallah M, Bulbanat B, AlMahmeed W, Ridha M et al..  2019.  Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40.. Curr Vasc Pharmacol.
Benda NC, Veinot TC, Sieck CJ, Ancker JS.  2020.  Broadband Internet Access Is a Social Determinant of Health!. Am J Public Health. 110(8):1123-1125.
Ennamuri S, Abramson E, Mauer E, Gerber LM, Nellis ME.  2020.  Changes in Clinical Course Before and After Do-Not-Resuscitate Order Placement in a Pediatric Intensive Care Unit Setting.. J Palliat Med.
Prigerson HG, Bao Y, Shah MA, M Paulk E, LeBlanc TW, Schneider BJ, Garrido MM, M Reid C, Berlin DA, Adelson KB et al..  2015.  Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.. JAMA Oncol. 1(6):778-84.
Al-Hajj S, Bcheraoui CEl, Daoud F, Khalil I, Moradi-Lakeh M, Abu-Raddad LJ, Hamadeh RR, Mokdad A.  2020.  Child and adolescent injury burden in the eastern mediterranean region: Findings from the Global Burden of Disease 1990-2017.. BMC Public Health. 20(1):433.
Al-Hajj S, Bcheraoui CEl, Daoud F, Khalil I, Moradi-Lakeh M, Abu-Raddad LJ, Hamadeh RR, Mokdad A.  2020.  Child and adolescent injury burden in the eastern mediterranean region: Findings from the Global Burden of Disease 1990-2017.. BMC Public Health. 20(1):433.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB et al..  2020.  Clinical Characteristics of Covid-19 in New York City.. N Engl J Med.
Magbanua MJesus M, Savenkov O, Asmus EJ, Ballman K, Scott JH, Park JW, Dickler M, Partridge AH, Carey LA, Winer E et al..  2020.  Clinical significance of circulating tumor cells in hormone receptor-positive metastatic breast cancer patients who received letrozole with or without bevacizumab.. Clin Cancer Res.
Gordhandas S, Kahn RM, Gamble C, Talukdar N, Maddy B, Nelson BBaltich, Askin G, Christos PJ, Holcomb K, Caputo TA et al..  2020.  Clinicopathologic features of endometrial cancer with mismatch repair deficiency.. Ecancermedicalscience. 14:1061.
Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al..  2020.  CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.
Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al..  2020.  CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.